Article Menu

Academic Editor

Silvio Maringhini
Subscribe SciFeed
Recommended Articles
Related Info Links
- PubMed/Medline
- Google Scholar
More by Authors Links

/ajax/scifeed/subscribe

Article Views

Citations -

Printed Edition

A printed edition of this Special Issue is available at MDPI Books....

Altmetric Share Help Cite Discuss in SciProfiles

Need Help?

Support

Find support for a specific problem in the support section of our website.

Get Support

Feedback

Please let us know what you think of our products and services.

Give Feedback

Information

Visit our dedicated information section to learn more about MDPI.

Get Information

Open AccessArticle

Article Versions Notes

Biomedicines 2024, 12(2), 413; https://doi.org/10.3390/biomedicines12020413

Action	Date	Notes	Link
article xml file uploaded	9 February 2024 15:23 CET	Original file	-
article xml uploaded.	9 February 2024 15:23 CET	Update	https://www.mdpi.com/2227-9059/12/2/413/xml
article pdf uploaded.	9 February 2024 15:23 CET	Version of Record	https://www.mdpi.com/2227-9059/12/2/413/pdf
article html file updated	9 February 2024 15:26 CET	Original file	-
article html file updated	12 February 2024 10:32 CET	Update	https://www.mdpi.com/2227-9059/12/2/413/html

Cite

Export citation file: BibTeX | EndNote | RIS

MDPI and ACS Style

Domański, P.; Piętak, M.; Kruczyk, B.; Jarosińska, J.; Mydlak, A.; Demkow, T.; Darewicz, M.; Sikora-Kupis, B.; Dumnicka, P.; Kamzol, W.; et al. Adverse Events of Cabozantinib as a Potential Prognostic Factor in Metastatic Renal Cell Carcinoma Patients: Real-World Experience in a Single-Center Retrospective Study. Biomedicines 2024, 12, 413. https://doi.org/10.3390/biomedicines12020413

AMA Style

Domański P, Piętak M, Kruczyk B, Jarosińska J, Mydlak A, Demkow T, Darewicz M, Sikora-Kupis B, Dumnicka P, Kamzol W, et al. Adverse Events of Cabozantinib as a Potential Prognostic Factor in Metastatic Renal Cell Carcinoma Patients: Real-World Experience in a Single-Center Retrospective Study. Biomedicines. 2024; 12(2):413. https://doi.org/10.3390/biomedicines12020413

Chicago/Turabian Style

Domański, Piotr, Mateusz Piętak, Barbara Kruczyk, Jadwiga Jarosińska, Anna Mydlak, Tomasz Demkow, Marta Darewicz, Bożena Sikora-Kupis, Paulina Dumnicka, Wojciech Kamzol, and et al. 2024. "Adverse Events of Cabozantinib as a Potential Prognostic Factor in Metastatic Renal Cell Carcinoma Patients: Real-World Experience in a Single-Center Retrospective Study" Biomedicines 12, no. 2: 413. https://doi.org/10.3390/biomedicines12020413

APA Style

Domański, P., Piętak, M., Kruczyk, B., Jarosińska, J., Mydlak, A., Demkow, T., Darewicz, M., Sikora-Kupis, B., Dumnicka, P., Kamzol, W., & Kucharz, J. (2024). Adverse Events of Cabozantinib as a Potential Prognostic Factor in Metastatic Renal Cell Carcinoma Patients: Real-World Experience in a Single-Center Retrospective Study. Biomedicines, 12(2), 413. https://doi.org/10.3390/biomedicines12020413

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Statistics

For more information on the journal statistics, click here.

Multiple requests from the same IP address are counted as one view.

Article Menu

Printed Edition

Article Versions Notes

Further Information

Guidelines

MDPI Initiatives

Follow MDPI